Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Medtronic Prestige Cervical Disc “Not Inferior” To Fusion – FDA Panel

This article was originally published in The Gray Sheet

Executive Summary

Medtronic Sofamor Danek's Prestige ST artificial cervical disc should be approved, contingent upon postmarket submission of seven-year follow up data to help ensure long-term durability, FDA's Orthopedic & Rehabilitation Devices Panel recommended Sept. 19
Advertisement

Related Content

FDA Panel Favors Medtronic’s Bryan Cervical Disc Despite Durability Question
FDA Panel Favors Medtronic’s Bryan Cervical Disc Despite Durability Question
Medtronic Preps For Upcoming FDA Panel Meetings On Stent, Spinal Disc
Medtronic Preps For Upcoming FDA Panel Meetings On Stent, Spinal Disc
Medtronic Loses ICD Market Share, Looks Ahead To U.S. Market Rebound
Zimmer’s Endius Purchase Is “Part One” Of Spinal Device Acquisition Plan
CMS Opens National Coverage Decision For Synthes’ Lumbar Disc
Medtronic Launches First Products In Interventional Spine Unit
Medtronic’s Prestige Artificial Disc Will Be Put To Test At FDA Panel
Medtronic’s Prestige Artificial Disc Will Be Put To Test At FDA Panel
Advertisement
UsernamePublicRestriction

Register

MT024017

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel